Antibodies against Anthrax: Mechanisms of Action and Clinical Applications
B. anthracis is a bioweapon of primary importance and its pathogenicity depends on its lethal and edema toxins, which belong to the A-B model of bacterial toxins, and on its capsule. These toxins are secreted early in the course of the anthrax disease and for this reason antibiotics must be administ...
Main Authors: | Thibaut Pelat, Philippe Thullier, Jeffrey W. Froude II |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-11-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/3/11/1433/ |
Similar Items
-
Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax
by: Bruce Huang, et al.
Published: (2015-09-01) -
Anthrax Toxin Detection: From In Vivo Studies to Diagnostic Applications
by: Jean-Nicolas Tournier, et al.
Published: (2020-07-01) -
Different mechanisms of two anti-anthrax protective antigen antibodies and function comparison between them
by: Siping Xiong, et al.
Published: (2019-11-01) -
Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax
by: Qi Tang, et al.
Published: (2018-12-01) -
Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax
by: Jean-Nicolas Tournier, et al.
Published: (2019-06-01)